Genome-wide protein QTL mapping identifies human plasma kallikrein as a post-translational regulator of serum uPAR levels

Genome-wide protein QTL mapping identifies human plasma kallikrein as a post-translational regulator of serum uPAR levels

The soluble cleaved urokinase plasminogen activator receptor (scuPAR) is a circulating protein detected in multiple diseases, including various cancers, cardiovascular disease, and kidney disease, where elevated levels of scuPAR have been associated with worsening prognosis and increased disease agg...

Full description

Bibliographic Details
Main Authors:	Portelli, Michael, Siedlinski, Mateusz, Stewart, Ceri E., Postma, Dirkje S., Nieuwenhuis, Maartje A., Vonk, Judith M., Nurnberg, Peter, Altmuller, Janine, Moffatt, M.F., Wardlaw, Andrew J., Parker, Stuart G., Connolly, Martin J., Koppelman, Gerard H., Sayers, Ian
Format:	Article
Language:	English
Published:	Federation of American Society of Experimental Biology 2014
Online Access:	http://eprints.nottingham.ac.uk/3171/ http://eprints.nottingham.ac.uk/3171/ http://eprints.nottingham.ac.uk/3171/ http://eprints.nottingham.ac.uk/3171/1/Portelli_Genome-wide_protein_QTL_mapping_identifies_human.pdf

Similar Items

Genome-wide protein QTL mapping identifies human plasma kallikrein as a post-translational regulator of serum uPAR levels
by: Portelli, Michael A., et al.
Published: (2014)

Genome-wide protein QTL mapping identifies human plasma kallikrein as a post-translational regulator of serum uPAR levels
by: Portelli, Michael A., et al.
Published: (2014)

uPAR regulates bronchial epithelial repair in vitro and is elevated in asthmatic epithelium
by: Stewart, Ceri E, et al.
Published: (2011)

Response
by: Sayers, Ian, et al.
Published: (2015)

uPAR's signaling two step
by: Leslie, Mitch
Published: (2007)

Secreted uPAR isoform 2 (uPAR7b) is a novel direct target of miR-221
by: Falkenberg, Natalie, et al.
Published: (2015)

Nicotinic Acetylcholine Receptor Variants Are Related to Smoking Habits, but Not Directly to COPD
by: Budulac, Simona E., et al.
Published: (2012)

A doxycycline-inducible urokinase receptor (uPAR) upregulates uPAR activities including resistance to anoikis in human prostate cancer cell lines
by: Hasanuzzaman, Mohammad, et al.
Published: (2007)

Identification of uPAR-positive Chemoresistant Cells in Small Cell Lung Cancer
by: Gutova, Margarita, et al.
Published: (2007)

A deficiency of uPAR alters endothelial angiogenic function and cell morphology
by: Balsara, Rashna D, et al.
Published: (2011)

uPAR induces epithelial–mesenchymal transition in hypoxic breast cancer cells
by: Lester, Robin D., et al.
Published: (2007)

uPAR-induced cell adhesion and migration: vitronectin provides the key
by: Madsen, Chris D., et al.
Published: (2007)

MMP-9 and uPAR regulated glioma cell migration
by: Veeravalli, Krishna Kumar, et al.
Published: (2012)

uPAR-targeted multimodal tracer for pre- and intraoperative imaging in cancer surgery
by: Boonstra, Martin C., et al.
Published: (2015)

First-in-human uPAR PET: Imaging of Cancer Aggressiveness
by: Persson, Morten, et al.
Published: (2015)

Characterization and function of human Ly-6/uPAR molecules
by: Kong, Hyun Kyung, et al.
Published: (2012)

Serum uPAR as Biomarker in Breast Cancer Recurrence: A Mathematical Model
by: Hao, Wenrui, et al.
Published: (2016)

Urokinase plasminogen activator receptor polymorphisms and airway remodelling in asthma
by: Ierodiakonou, Despo, et al.
Published: (2016)

Urokinase plasminogen activator receptor polymorphisms and airway remodelling in asthma
by: Ierodiakonou, Despo, et al.
Published: (2016)

Airway and peripheral urokinase plasminogen activator receptor is elevated in asthma, and identiﬁes a severe, nonatopic subset of patients
by: Portelli, Michael A., et al.
Published: (2016)

Correction: Identification of a New Epitope in uPAR as a Target for the Cancer Therapeutic Monoclonal Antibody ATN-658, a Structural Homolog of the uPAR Binding Integrin CD11b (αM)
Published: (2014)

Correction: Identification of a New Epitope in uPAR as a Target for the Cancer Therapeutic Monoclonal Antibody ATN-658, a Structural Homolog of the uPAR Binding Integrin CD11b (αM)
Published: (2014)

Identification of a New Epitope in uPAR as a Target for the Cancer Therapeutic Monoclonal Antibody ATN-658, a Structural Homolog of the uPAR Binding Integrin CD11b (αM)
by: Xu, Xiang, et al.
Published: (2014)

Novel insight into uPAR function in the bronchial epithelium in asthma using functional genomics
by: Bhaker, Sangita
Published: (2017)

The superoxide scavenger TEMPOL induces urokinase receptor (uPAR) expression in human prostate cancer cells
by: Lejeune, Danielle, et al.
Published: (2006)

GPI-anchored uPAR requires Endo180 for rapid directional sensing during chemotaxis
by: Sturge, Justin, et al.
Published: (2003)

The prognostic value of the suPARnostic® ELISA in HIV-1 infected individuals is not affected by uPAR promoter polymorphisms
by: Schneider, Uffe V, et al.
Published: (2007)

Cathepsin B and uPAR Knockdown Inhibits Tumor-induced Angiogenesis by Modulating VEGF Expression in Glioma
by: Malla, Rama Rao, et al.
Published: (2011)

Monomer–dimer dynamics and distribution of GPI-anchored uPAR are determined by cell surface protein assemblies
by: Caiolfa, Valeria R., et al.
Published: (2007)

Effects of ulinastatin and docetaxel on breast cancer invasion and expression of uPA, uPAR and ERK
by: Luo, Jie, et al.
Published: (2011)

1,25-Dihydroxyvitamin D(3) Inhibits Podocyte uPAR Expression and Reduces Proteinuria
by: Ma, Jianchao, et al.
Published: (2013)

The role of uPAR in epithelial-mesenchymal transition in small airway epithelium of patients with chronic obstructive pulmonary disease
by: Wang, Qin, et al.
Published: (2013)

The Many Spaces of uPAR: Delivery of Theranostic Agents and Nanobins to Multiple Tumor Compartments through a Single Target
by: O'Halloran, Thomas V., et al.
Published: (2013)

Urokinase Plasminogen Activator Receptor (uPAR) Targeted Nuclear Imaging and Radionuclide Therapy
by: Li, Dan, et al.
Published: (2013)

Diabetes-Induced Superoxide Anion and Breakdown of the Blood-Retinal Barrier: Role of the VEGF/uPAR Pathway
by: El-Remessy, Azza B., et al.
Published: (2013)

HIV-1 Infected Lymphoid Organs Upregulate Expression and Release of the Cleaved Form of uPAR That Modulates Chemotaxis and Virus Expression
by: Nebuloni, Manuela, et al.
Published: (2013)

Tumor-associated soluble uPAR-directed endothelial cell motility and tumor angiogenesis
by: Rao, J S, et al.
Published: (2013)

Urokinase-type plasminogen activator receptor (uPAR) as a promising new imaging target: potential clinical applications
by: Persson, Morten, et al.
Published: (2013)

uPAR and cathepsin B knockdown inhibits radiation-induced PKC integrated integrin signaling to the cytoskeleton of glioma-initiating cells
by: ALAPATI, KIRANMAI, et al.
Published: (2012)

Apoptosis Induced by Knockdown of uPAR and MMP-9 is Mediated by Inactivation of EGFR/STAT3 Signaling in Medulloblastoma
by: Kotipatruni, Ramaprasada Rao, et al.
Published: (2012)